Meridian Bioscience reported $13.75M in EBIT for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Abbott ABT:US $ 2522M 1123M
Atrion ATRI:US 9.48M 317K
Becton, Dickinson and BDX:US $ 776M 250M
Bio Rad Laboratories BIO:US $ 163.22M 46.13M
Cerulean Pharma CERU:US $ -12668940 3.51M
Cerus CERS:US $ -11126000 3.28M
Genmark Diagnostics GNMK:US $ -2087000 821K
Luminex LMNX:US $ 13.46M 2.96M
Meridian Bioscience VIVO:US $ 13.75M 2.67M
Myriad Genetics MYGN:US $ -79900000 60.9M
Neogen NEOG:US $ 21.74M 1.49M
Orasure Technologies OSUR:US $ -13513000 15.09M
Oxford Immunotec Global OXFD:US 275K 10.11M
Quidel QDEL:US $ 281.84M 257.51M
Rockwell Medical RMTI:US -6972000 851K
Sientra SIEN:US $ -11694000 2.54M
Staar Surgical STAA:US $ 7.84M 2.81M
Thermo Fisher Scientific TMO:US $ 2296M 56M
Trinity Biotech TRIB:US 6.29M 3.21M